{
    "clinical_study": {
        "@rank": "131292", 
        "arm_group": {
            "arm_group_label": "treatment", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the safety and efficacy of allogeneic\n      adipose-derived stem cells (ALLO-ASC) in patients with lateral epicondylitis."
        }, 
        "brief_title": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Tennis Elbow", 
        "condition_browse": {
            "mesh_term": "Tennis Elbow"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Older than 19 years.\n\n          2. Patients who are diagnosed as lateral epicondylitis (Pain\u22654 of VAS during activity).\n\n          3. Patients who has sustained pain more than 6 months\n\n          4. Patients who lasting for pain in spite of conservative therapy\n\n          5. Patients who have one lesion under ultrasonic photography\n\n          6. Negative for urine beta-HCG for women of childbearing age\n\n          7. Patient who is able to give written informed consent prior to study start and to\n             comply with the study requirements\n\n        Exclusion Criteria:\n\n          1. Patients who has been experienced steroid and prolotherapy or other treatment within\n             3 months at screening time\n\n          2. Patients who have lesion size of width and length more than 1 cm using ultrasonic\n             photography test\n\n          3. Patients who were accompanied by the disease as follows: A. Arthritis of related\n             joint to the target lesiom (ex, cubital osteo- arthritis), B.Synovitis of related\n             joint to the target lesion, C.Entrapment of related nerve to the target lesion(ex,\n             radial tunnel syndrome), D.Generalized pain syndrome, E.Radiculopathy related to the\n             target lesion(ex, cervical spodylosis ,cervical radicular syndrome), F.Rheumatoid\n             arthritis, G.Previous fracture of arm causing limitations in arm function, H.Impaired\n             sensibility, I.Paralysis\n\n          4. Patients who are pregnant or breast-feeding\n\n          5. Patients who have allergic or hypersensitive reaction to bovine-derived proteins or\n             fibrin glue\n\n          6. Patients who have history of fracture and dislocation at Ipsilateral upper extremity\n             within 2 years recently\n\n          7. Patients who have operation history in tendon, ligament and bone at Ipsilateral upper\n             extremity within 2 years recently\n\n          8. Patients who are unwilling to use an \"effective\" method of contraception during the\n             study\n\n          9. Patients who have a clinically relevant history of abuse of alcohol or drugs\n\n         10. Patients who are considered not suitable for the study by investigator\n\n         11. Patients who have experienced treatment with stem cell before this study\n\n         12. Patients who currently enrolled in another investigational drug study within 30 days\n             of screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131077", 
            "org_study_id": "ALLO-ASC-TI-201"
        }, 
        "intervention": [
            {
                "arm_group_label": "treatment", 
                "intervention_name": "ALLO-ASC-TI", 
                "intervention_type": "Biological", 
                "other_name": "Allogenic adipose-derived stem cell"
            }, 
            {
                "arm_group_label": "treatment", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "0.9% Saline"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Lateral Epicondylitis", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "contact": {
                    "email": "chung60611@gmail.com", 
                    "last_name": "S G Chung, M.D., Ph. D", 
                    "phone": "82-2-2072-3954"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "RMPJH@yuhs.ac", 
                    "last_name": "J H Park, M.D.", 
                    "phone": "82-2-2019-3491"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Gangnam Severance Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hipson4206@naver.com", 
                    "last_name": "C W Lee, M.D., Ph.D.", 
                    "phone": "82-2-1688-9797(direct 1812)"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Nanoori hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "khchoi@amc.seoul.kr", 
                    "last_name": "K H Choi, M.D., Ph.D.", 
                    "phone": "Tel.82-2-3010-3800"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Asan Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Donkim21@gmail.com", 
                    "last_name": "D K Kim, M.D., Ph. D", 
                    "phone": "82-2-6299-1866"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chung-Ang University Hosptal"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi-center, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase I/II Clinical Study to Evaluate Safety and Efficacy of Allogeneic Adipose-derived Stem Cells for the Treatment of Lateral Epicondylitis", 
        "overall_contact": {
            "email": "suncg@snu.ac.kr", 
            "last_name": "S G Chung, MD., PhD", 
            "phone": "82-2-2072-3954"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "S G Chung, M.D., Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Ministry of Food and Drug Safety (MFDS)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Clinically measured abnormality of laboratory tests and adverse events", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "Week 12"
            }, 
            {
                "description": "Improvement of VAS pain score at 12 weeks compared to baseline per each group", 
                "measure": "Efficacy", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131077"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Changes in the VAS pain score during activity per each group", 
                "measure": "VAS pain score", 
                "safety_issue": "No", 
                "time_frame": "week 2, week 6 and week 12"
            }, 
            {
                "description": "Improvement rate of VAS pain score at rest per each group", 
                "measure": "VAS pain score", 
                "safety_issue": "No", 
                "time_frame": "week 2, week 6 and week 12"
            }, 
            {
                "description": "Change in Modified Mayo Clinic Performance Index per each group", 
                "measure": "Modified Mayo Clinic Performance Index", 
                "safety_issue": "No", 
                "time_frame": "week 2, week 6 and week 12"
            }, 
            {
                "description": "Change in analysis of lesion size per each group", 
                "measure": "Ultrasonic photography", 
                "safety_issue": "Yes", 
                "time_frame": "week 6 and week 12"
            }
        ], 
        "source": "Anterogen Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Anterogen Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}